Skip to main content
. 2017 Nov 26;23:5630–5636. doi: 10.12659/MSM.903903

Table 2.

Efficacy in NPC patients among the CT, SRT and CT + SRT group.

Group CR PR SD χ2 P
C group 34 (29.82) 54 (47.37) 26 (22.81) 15.53 0.004
SR group 33 (30.28) 59 (54.13) 17 (15.60)
C+SR group 43 (40.57) 58 (54.72) 5 (4.72)

NPC – nasopharyngeal carcinoma; CT – chemotherapy; SRT – stereotactic radiotherapy; CR – complete response; PR – partial response; SD – disease stable.